scispace - formally typeset
Open AccessJournal ArticleDOI

Attitudes towards and participation in randomised clinical trials in oncology: A review of the literature

Peter M. Ellis
- 01 Aug 2000 - 
- Vol. 11, Iss: 8, pp 939-945
Reads0
Chats0
TLDR
There is a paucity of research examining the association between knowledge about clinical trials, anxiety associated with a new cancer diagnosis and willingness to participate in randomised clinical trials.
About
This article is published in Annals of Oncology.The article was published on 2000-08-01 and is currently open access. It has received 265 citations till now. The article focuses on the topics: Clinical study design & Clinical trial.

read more

Citations
More filters
Journal ArticleDOI

Public Attitudes Toward Participation in Cancer Clinical Trials

TL;DR: The results indicate that the primary problem with accrual is not the attitudes of patients, but rather that the loss of potential participants is the result of the unavailability of an appropriate clinical trial and the disqualification of large numbers of patients.
Journal ArticleDOI

Reasons for participating in randomised controlled trials: conditional altruism and considerations for self.

TL;DR: Recognition of conditional altruism has implications for planning trial recruitment communications to promote informed and voluntary trial participation and to recognise that participation will benefit them personally.
Journal ArticleDOI

Randomized Clinical Trials in Oncology: Understanding and Attitudes Predict Willingness to Participate

TL;DR: It is suggested that women who have a better understanding of issues about clinical trials have more favorable attitudes toward randomized trials and are more willing to consider participation in a clinical trial.
Journal ArticleDOI

Research into complementary and alternative medicine: problems and potential.

TL;DR: The growing use of unsubstantiated complementary and alternative medicine therapies by people in the United States along with its increasing coverage by third party payers encouraged Congress to create the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health to explore complementary andAlternative Medicine practices in the context of rigorous science.
References
More filters
Journal ArticleDOI

Evidence based medicine: what it is and what it isn't.

TL;DR: Evidence Based Medicine (IBM) as discussed by the authors is the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients, which is a hot topic for clinicians, public health practitioners, purchasers, planners and the public.
Journal ArticleDOI

Equipoise and the ethics of clinical research.

TL;DR: An alternative concept of equipoise is suggested, which would be based on present or imminent controversy in the clinical community over the preferred treatment, which is satisfied if there is genuine uncertainty within the expert medical community--not necessarily on the part of the individual investigator--about the preferredreatment.
Journal ArticleDOI

Information and participation preferences among cancer patients

TL;DR: Most patients in each age group displayed high levels of hope, preferences for open communication about their illness, and a desire for maximum amounts of information.
Journal ArticleDOI

Information Needs and Decisional Preferences in Women With Breast Cancer

TL;DR: Priorities for information identified in this study provide an empirical basis to guide communication with women seeking care for breast cancer and suggest systematic approaches to assess and respond to women's desired level of participation in treatment decision making need to be evaluated.
Related Papers (5)
Trending Questions (2)
In which phase of clinical trials healthy volunteers are enrolled?

There are a variety of physician and patient characteristics which have previously been shown to influence participation in randomised clinical trials.

How patients are enrolled in clinical trials?

Further research also is needed to evaluate strategies to better inform patients about clinical trials.